Status:
UNKNOWN
Role of Left Ventricular Pacing Site
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Heart Failure
Cardiomyopathy, Dilated
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cardiac resynchronization therapy has been shown to be effective in reducing symptoms and mortality in heart failure patients. However, very few is known about the importance of the left ventricular p...
Detailed Description
Background. Cardiac resynchronization therapy has been shown to be effective in reducing symptoms and mortality in heart failure patients. However, very few is known about the importance of the left v...
Eligibility Criteria
Inclusion
- Heart failure referred for cardiac resynchronization therapy
- NYHA Class III or IV
- Informed consent form signed
Exclusion
- Hypertension not controlled by treatment
- Coronary ischemia not controlled by treatment
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00221780
Start Date
November 1 2003
End Date
December 1 2007
Last Update
June 29 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Cardiologique du Haut Lévêque, Rythmology department, Pr CLEMENTY, 3rd Floor
Pessac, France, 33604